• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与非霍奇金淋巴瘤:2005 年基于台湾全民健康保险数据库的流行率与年发病率分析。

Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan.

机构信息

Department of Internal Medicine, National Taiwan University College of Medicine, Taipei; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Ann Oncol. 2012 Jan;23(1):153-158. doi: 10.1093/annonc/mdr334. Epub 2011 Jul 15.

DOI:10.1093/annonc/mdr334
PMID:21765043
Abstract

BACKGROUND

The association between diabetes and non-Hodgkin's lymphoma (NHL) is rarely studied and the risk associated with insulin use is not known.

MATERIALS AND METHODS

The crude and age-standardized trends of NHL incidence in the general population from 1979 to 2007 were first calculated. NHL prevalence and annual incidence in 2005 were calculated in 329,198 insurants aged≥45 years from a random sample of 1,000,000 insurants of the National Health Insurance. The risk factors were evaluated using logistic regression.

RESULTS

NHL incidence trends increased significantly in either sex. A total of 1079 and 148 NHL cases were identified for prevalence and incidence analyses, respectively. The respective prevalence (per 100,000) for diabetic and nondiabetic subjects was 480.2 and 269.9 (P<0.01), and the respective incidence (per 100,000) was 70.9 and 35.3 (P<0.01). Odds ratio for diabetic versus nondiabetic subjects after adjustment for age, sex, occupation, and living region was 1.51 (95% confidence interval 1.33-1.71) for prevalence and 1.48 (1.06-2.06) for incidence. In diabetic patients, the adjusted odds ratio for insulin users versus nonusers was 1.63 (1.23-2.15) for prevalence and 2.52 (1.37-4.64) for incidence.

CONCLUSIONS

NHL incidence is increasing in Taiwan. Diabetes and insulin use are associated with a higher risk.

摘要

背景

糖尿病与非霍奇金淋巴瘤(NHL)之间的关联很少被研究,而与胰岛素使用相关的风险尚不清楚。

材料和方法

首先计算了 1979 年至 2007 年普通人群 NHL 发病率的粗发病率和年龄标准化趋势。从 100 万被保险人的随机样本中,选择了 329198 名年龄≥45 岁的被保险人,计算了 2005 年 NHL 的患病率和年发病率。使用逻辑回归评估危险因素。

结果

无论性别如何,NHL 发病率趋势均明显上升。在患病率和发病率分析中,分别确定了 1079 例和 148 例 NHL 病例。糖尿病和非糖尿病患者的相应患病率(每 10 万人)分别为 480.2 和 269.9(P<0.01),相应的发病率(每 10 万人)分别为 70.9 和 35.3(P<0.01)。调整年龄、性别、职业和居住地区后,糖尿病与非糖尿病患者相比,患病率的优势比为 1.51(95%置信区间为 1.33-1.71),发病率的优势比为 1.48(1.06-2.06)。在糖尿病患者中,调整后的胰岛素使用者与非使用者相比,患病率的优势比为 1.63(1.23-2.15),发病率的优势比为 2.52(1.37-4.64)。

结论

台湾的 NHL 发病率正在上升。糖尿病和胰岛素的使用与更高的风险相关。

相似文献

1
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan.糖尿病与非霍奇金淋巴瘤:2005 年基于台湾全民健康保险数据库的流行率与年发病率分析。
Ann Oncol. 2012 Jan;23(1):153-158. doi: 10.1093/annonc/mdr334. Epub 2011 Jul 15.
2
Diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese.糖尿病、胰岛素使用与胃癌:基于台湾人群的分析。
J Clin Gastroenterol. 2013 Jul;47(6):e60-4. doi: 10.1097/MCG.0b013e31827245eb.
3
Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.系统性红斑狼疮与非霍奇金淋巴瘤的双向关系:一项基于全国人口的研究。
Rheumatology (Oxford). 2019 Jul 1;58(7):1245-1249. doi: 10.1093/rheumatology/kez011.
4
Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.2型糖尿病与肾癌风险:一项基于国民健康保险的回顾性队列分析
PLoS One. 2015 Nov 11;10(11):e0142480. doi: 10.1371/journal.pone.0142480. eCollection 2015.
5
Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.台湾的糖尿病、胰岛素使用与非霍奇金淋巴瘤死亡率。
Metabolism. 2012 Jul;61(7):1003-9. doi: 10.1016/j.metabol.2011.11.015. Epub 2012 Jan 10.
6
Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).非霍奇金淋巴瘤-淋巴结内和淋巴结外:20 年死亡率、生存率和生物学行为比较分析,按年龄、性别、种族、分期、细胞形态/组织学、队列入组时间-时期和疾病持续时间分层:对 1975-2016 年诊断年的 384651 例非霍奇金淋巴瘤(NHL)总病例(包括 261144 例淋巴结内和 123507 例淋巴结外病例)进行的系统评价:(SEER*Stat 8.3.6)。
J Insur Med. 2023 Jul 1;50(1):1-35. doi: 10.17849/insm-50-1-1-35.1.
7
Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.北美人群胃肠道非霍奇金淋巴瘤的流行病学及风险因素变化:基于人群的研究
Am J Gastroenterol. 2008 Jul;103(7):1762-9. doi: 10.1111/j.1572-0241.2008.01794.x. Epub 2008 Jun 28.
8
Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies.糖尿病与非霍奇金淋巴瘤风险:观察性研究的荟萃分析
Diabetes Care. 2008 Dec;31(12):2391-7. doi: 10.2337/dc08-1034.
9
Diabetes and risk of prostate cancer: a study using the National Health Insurance.糖尿病与前列腺癌风险:基于国民健康保险的研究。
Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.
10
Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.1974 - 1993年意大利撒丁岛非霍奇金淋巴瘤和霍奇金病的发病率
Haematologica. 2001 Jan;86(1):58-63.

引用本文的文献

1
Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin Lymphoma.2型糖尿病与非霍奇金淋巴瘤共同发病机制的生物标志物发现及机制洞察的综合方法
Diabetes Metab Syndr Obes. 2025 Jan 31;18:267-282. doi: 10.2147/DMSO.S503449. eCollection 2025.
2
Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study.血糖状态与血液系统恶性肿瘤风险之间的肥胖无关关联:一项基于全国人群的纵向队列研究。
Cancers (Basel). 2021 Sep 23;13(19):4760. doi: 10.3390/cancers13194760.
3
[The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
[糖尿病和弥漫性大B细胞淋巴瘤(DLBCL)治疗期间高血糖对弥漫性大B细胞淋巴瘤患者的预后影响]
Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):151-157. doi: 10.3760/cma.j.issn.0253-2727.2021.02.011.
4
Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis.糖尿病预示弥漫性大B细胞淋巴瘤患者生存率较低:一项倾向评分匹配分析。
Cancer Manag Res. 2019 Apr 9;11:2849-2870. doi: 10.2147/CMAR.S185319. eCollection 2019.
5
Type 2 diabetes mellitus is more prevalent among patients with thyroid carcinoma and influences overall survival: a propensity score matching analysis.
Oncotarget. 2017 Oct 31;8(57):97528-97536. doi: 10.18632/oncotarget.22179. eCollection 2017 Nov 14.
6
Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.二甲双胍与2型糖尿病患者患胃癌风险之间的关联:队列研究的荟萃分析
Oncotarget. 2017 Apr 8;8(33):55622-55631. doi: 10.18632/oncotarget.16973. eCollection 2017 Aug 15.
7
Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up.台湾糖尿病患者17年随访期间与癌症及非癌症相关死亡相关的因素
PLoS One. 2016 Dec 1;11(12):e0147916. doi: 10.1371/journal.pone.0147916. eCollection 2016.
8
A 9-year Trend in the Prevalence of Allergic Disease Based on National Health Insurance Data.基于国民健康保险数据的过敏性疾病患病率9年趋势
J Prev Med Public Health. 2015 Nov;48(6):301-9. doi: 10.3961/jpmph.15.011. Epub 2015 Nov 13.
9
Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.2型糖尿病与肾癌风险:一项基于国民健康保险的回顾性队列分析
PLoS One. 2015 Nov 11;10(11):e0142480. doi: 10.1371/journal.pone.0142480. eCollection 2015.
10
Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.二甲双胍可降低台湾2型糖尿病患者患甲状腺癌的风险。
PLoS One. 2014 Oct 10;9(10):e109852. doi: 10.1371/journal.pone.0109852. eCollection 2014.